About Us


Haltex Therapeutics was incorporated in 2022 to facilitate the collaboration of medical experts, pharmaceutical companies, academia, domain experts and social investors. Haltex Therapeutics has one clear goal: bring a safe and effective therapy against PXE and other ectopic calcifications to market for a price that ensures accessibility for all patients.

The collaboration

Our core team

Antrea Kyriakidou

Regulatory affairs

Cristian Fabbri


Ezequiel Palmiotti

Financial controller

Javier Castorina

Executive director – Pharmaceutical development

Kees Hörchner


Marcos Mosteirin

Operations leader

Vincent van der Wel

Executive director – Clinical development